Last updated: April 25, 2026
Who Supplies “PhyraGO” (phyrago) Materials, Services, and Manufacturing?
No complete, authoritative supplier map for “phyrago/PhyraGO” can be produced from the information provided. Without an unambiguous drug identity (active ingredient, brand/generic name spelling, and jurisdictional labeling), any list of suppliers would be speculative and not actionable for patent, regulatory, or sourcing decisions.
What is “phyrago” in official sources?
A valid supplier answer requires a match to at least one of the following:
- The drug’s active pharmaceutical ingredient (API) name and/or INN/USAN identifier
- The brand name spelling as filed with regulators and on labels (including capitalization and suffixes)
- The marketing authorization holder (MAH) and product dossier identifiers by country
- The manufacturing sites listed on regulatory submissions (eCTD/CTD, PL, BLA/ANDA, or local equivalents)
Why supplier lists cannot be safely constructed here
Pharmaceutical supplier networks are buildable only from product-specific identifiers that tie:
- API makers to DMF/CEP entries
- Finish dosage manufacturers to GMP site listings and submission sections
- Logistics, packaging, and analytical service providers to CMC module references
- Patent ownership and licensing to MAH/assignee and prosecution history
With “phyrago” unconfirmed, there is no reliable basis to name suppliers without risking misattribution (wrong molecule, wrong brand, or wrong product strength/formulation).
Key Takeaways
- A supplier list for “phyrago/PhyraGO” requires a verified product identity (API and official brand spelling).
- Without that, naming suppliers would be speculative rather than evidence-based.
- Patent-grade supplier mapping must be anchored to regulator-facing identifiers (API dossiers, GMP sites, and MAH listings).
FAQs
-
What counts as a “supplier” for a drug sourcing map?
Typically API manufacturers, finished-dose manufacturers, label/packaging providers, analytical testing labs, and distribution partners tied to regulatory filings.
-
Can I use a brand name alone to identify suppliers?
Only if the brand name matches an official labeling entry tied to a specific MAH and product dossier.
-
What evidence is required for a defensible supplier list?
Regulators’ product dossiers, GMP site listings, DMF/CEP references, and MAH-linked submission documents.
-
Do suppliers vary by strength or dosage form?
Yes. Different strengths or forms often use distinct manufacturing sites and sometimes different API suppliers.
-
How do patents affect supplier identification?
Patent ownership and licensing can link to the MAH and prosecution entities that appear in regulatory submissions, which then narrows supplier candidates.
References
[1] No cited sources available because no product identifiers for “phyrago/PhyraGO” were provided in the prompt.
